The many faces of the genetics contribution to temporomandibular joint disorder

Orthodontics and Craniofacial Research

Volumn 11, Issue 3, 2008, Pages 125-135

  Oakley, M ^a   Vieira, A R ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Myofascial pain dysfunction syndrome; Pain; Temporomandibular joint; Temporomandibular joint dysfunction syndrome

Indexed keywords

CYTOKINE;

ANIMAL; GENE EXPRESSION PROFILING; GENETICS; HUMAN; PAIN THRESHOLD; REVIEW; SEXUAL DEVELOPMENT; TEMPOROMANDIBULAR JOINT DISORDER;

ANIMALS; CYTOKINES; GENE EXPRESSION PROFILING; HUMANS; PAIN THRESHOLD; SEX CHARACTERISTICS; TEMPOROMANDIBULAR JOINT DISORDERS;

EID: 54049105765     PISSN: 16016335     EISSN: 16016343     Source Type: Journal    
DOI: 10.1111/j.1601-6343.2008.00426.x     Document Type: Article

References (86)

1. Verhaak PF, Kerssens JJ, Dekker J, Sorbi MJ, Bensing JM. Prevalence of chronic benign pain disorder among adults: a review of the literature. Pain 1998 2 : 49 53.
2. Pereira FJ Jr., Vieira AR, Prado R, Miasato JM. Epidemiology and etiology of TMD. Rev Gaúcha Odontol 2004 52 : 117 21.
3. Williamson M. Fibromyalgia: A Comprehensive Approach. New York : Walker and Company 1996.
4. Woolf CJ, Salter MW. Neuronal plasticity: increasing the gain in pain. Science 2000 288 : 1765 8.
5. Lund JP, Lavigne GJ, Dubner R, Sessle BJ. Orofacial Pain. From Basic Science to Clinical Management, 1st edn. Carol Stream : Quintessence Publishing Co., Inc. 2001.
6. Beecher HK. Measurement of Subjective Responses, 1st edn. New York : Oxford University Press 1959.
7. Mogil JS. Genetic linkage mapping and association studies of pain-related traits. In : Justins DM, editor. Pain 2005 - An Updated Review. Seattle : IASP Press 2005. pp. 209 15.
8. Hart TC, Pihlstrom BL, Tabak LA. Oral health research at the crossroads: translate we must J Endod 2004 30 : 684 8.
9. Roda PP, Bagan JV, Fernandez JMD, Bazan SH, Soriano YJ. Review of temporomandibular joint pathology. Part I: Classification, epidemiology and risk factors. Med Oral Patol Oral Cir Bucal 2007 12 : E292 8.
10. Uyanik JM, Murphy E. Evaluation and management of TMDs, Part 1. History, epidemiology, classification, anatomy, and patient evaluation. Dent Today 2003 22 : 140 5.
11. Fricton JR. The relationship of temporomandibular disorders and fibromyalgia: implications for diagnosis and treatment. Curr Pain Headache Rep 2004 8 : 355 63.
12. Shah N. Gender issues and oral health in elderly Indians. Int Dent J 2003 53 : 475 84.
13. Gesch D, Bernhardt O, Mack F, John U, Kocher T, Alte D. Dental occlusion and subjective temporomandibular joint symptoms in men and women. Results of the study of health in Pomerania (SHIP). Schweiz Monatsschr Zahnmed 2004 114 : 573 80.
14. Tuerlings V, Limme M. The prevalence of temporomandibular joint dysfunction in the mixed dentition. Eur J Orthod 2004 26 : 311 20.
15. Schmitter M, Rammelsberg P, Hassel A. The prevalence of signs and symptoms of temporomandibular disorders in very old subjects. J Oral Rehabil 2005 32 : 467 73.
16. Abou-Atme YS, Zawaki KH, Melis M. Prevalence, intensity, and correlation of different TMJ symptoms in Lebanese and Italian subpopulations. J Contemp Dent Pract 2006 7 : 71 8.
17. Dodić S, Stanisić-Sinobad D, Vukadinović M, Milić A, Sinobad V. The prevalence of craniofacial disorders in the military population of the Republic of Serbia. Med Pregl 2006 59 : 259 64.
18. Vieira AR, Gamboa GR. Dental characteristics of a cohort from the Cebu province. Sun Star Cebu 2006 24 : 203.
19. Nilsson IM. Reliability, validity, incidence and impact of temporomandibular pain disorders in adolescents. Swed Dent J 2007 183 (Suppl 7 86.
20. John MT, Dworkin SF, Mancl LA. Reliability of clinical temporomandibular disorder diagnosis. Pain 2005 118 : 61 9.
21. Manfredini D, Chiappe G, Bosco M. Research diagnostic criteria for temporomandibular disorders (RDC/TMD) axis I diagnosis inan Italian patient population. J Oral Rehabil 2006 33 : 551 8.
22. National Institute of Health Technology Assessment Conference Statement : Management of temporomandibular disorders. J Am Dent Assoc 1996 127 : 1595 606.
23. Buckingham RB, Braun T, Harinstein DA, Oral K, Bauman D, Bartynski W et al. Temporomandibular joint dysfunction syndrome: a close association with systemic joint laxity (the hypermobile joint syndrome). Oral Surg Oral Med Oral Pathol 1991 72 : 514 9.
24. Magnusson T, Egermarki I, Carlsson GE. A prospective investigation over two decades on signs and symptoms of temporomandibular disorders and associated variables. A final summary. Acta Odontol Scand 2005 63 : 99 109.
25. Eggleston DW. The interrelationship of stress and degenerative diseases. J Prosthet Dent 1980 44 : 541 4.
26. Raphael KG, Marbach JJ, Gallagher RM, Dohrenwend BP. Myofascial TMD does not run in families. Pain 1999 80 : 15 22.
27. Heiberg A, Heloe B, Heiberg AN, Heloe LA, Magnus P, Berg K et al. Myofascial pain dysfunction (MPD) syndrome in twins. Community Dent Oral Epidemiol 1980 8 : 434 6.
28. Stohler CS. Taking stock: from chasing occlusal contacts to vulnerability alleles. Orthod Craniofac Res 2004 7 : 157 61.
29. Woda A, Pionchon P. A unified concept of idiopathic orofacial pain: pathophysiologic features. J Orofac Pain 2000 14 : 196 212.
30. Mao JJ, Nah HD. Growth and development: hereditary and mechanical modulations. Am J Orthod Dentofacial Orthop 2004 125 : 676 89.
31. Patterson GT, Braun TW, Sotereanos GC. Surgical correction of the dentofacial abnormality in Hallerman-Streiff syndrome. J Oral Maxillofac Surg 1982 40 : 380 4.
32. Buskila D. Genetics of chronic pain states. Best Pract Res Clin Rheumatol 2007 21 : 535 47.
33. Mogil JS, Ritchie J, Smith SB, Strasburg K, Kaplan L, Wallace MR et al. Melanocortin-1 receptor gene variants affect pain and mu-opioid analgesia in mice and humans. J Med Genet 2005 42 : 583 7.
34. Zubieta JK, Heitzeg MM, Smith YR, Bueller JA, Xu K, Xu Y et al. COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science 2003 299 : 1240 3.
35. Diatchenko L, Slade GD, Nackley AG, Bhalang K, Sigurdsson A, Belfer I et al. Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum Mol Genet 2005 14 : 135 43.
36. Fillingim RB, Kaplan L, Staud R, Ness TJ, Glover TL, Campbell CM et al. The A118G single nucleotide polymorphism of the mu-opioid receptor gene (OPRM1) is associated with pressure pain sensitivity in humans. J Pain 2005 6 : 159 67.
37. Bondy B, Spaeth M, Offenbaecher M, Glatzeder K, Stratz T, Schwartz M et al. The T102C polymorphism of the 5-HT2A-receptor gene in fibromyalgia. Neurobiol Dis 1999 6 : 433 9.
38. Offenbaecher M, Bondy B, Jonge S, Glatzeder K, Kruger M, Schoeps P et al. Possible association of fibromyalgia with a polymorphism in the serotonin transporter gene regulatory region. Arthritis Rheum 1999 42 : 2482 8.
39. Gursoy S, Erdal E, Herken H, Madenci E, Alasehirli B, Erdal N. Significance of catechol-O-methyltransferase gene polymorphism in fibromyalgia syndrome. Rheumatol Int 2003 23 : 104 7.
40. Pata C, Erdal E, Yazc K, Camdeviren H, Ozkaya M, Ulu O. Association of the-1438 G/A and 102 T/C polymorphism of the 5-Ht2A receptor gene with irritable bowel syndrome. J Clin Gastroenterol 2004 38 : 561 6.
41. Solovieva S, Leino-Arjas P, Saarela J, Luoma K, Raininko R, Riihimaki H. Possible association of interleukin 1 gene locus polymorphisms with low back pain. Pain 2004 109 : 8 19.
42. Estevez M, Gardner KL. Update on the genetics of migraine. Hum Genet 2004 114 : 225 35.
43. Shoskes DA, Albakri Q, Thomas K, Cook D. Cytokine polymorphisms in men with chronic prostatitis/chronic pelvic pain syndrome: association with diagnosis and treatment response. J Urol 2002 168 : 331 5.
44. Jeremias J, Ledger WJ, Witkin SS. Interleukin 1 receptor antagonist gene polymorphism in women with vulvar vestibulitis. Am J Obstet Gynecol 2000 182 : 283 5.
45. Babula O, Danielsson I, Sjoberg I, Ledger WJ, Witkin SS. Altered distribution of mannose-binding lectin alleles at exon I codon 54 in women with vulvar vestibulitis syndrome. Am J Obstet Gynecol 2004 191 : 762 6.
46. Foster DC, Sazenski TM, Stodgell CJ. Impact of genetic variation in interleukin-1 receptor antagonist and melanocortin-1 receptor genes on vulvar vestibulitis syndrome. J Reprod Med 2004 49 : 503 9.
47. Mogil JS. The genetic mediation of individual differences in sensitivity to pain and its inhibition. Proc Natl Acad Sci USA 1999 96 : 7744 51.
48. Mogil JS, Wilson SG, Chesler EJ, Rankin AL, Nemmani KV, Lariviere WR et al. The melanocortin-1 receptor gene mediates female-specific mechanisms of analgesia in mice and humans. Proc Natl Acad Sci U S A 2003 1000 : 4867 72.
49. Nagasako EM, Oaklander AL, Dworkin RH. Congenital insensitivity to pain: an update. Pain 2003 101 : 213 9.
50. Herken H, Erdal E, Mutlu N, Barlas O, Cataloluk O, Oz F et al. Possible association of temporomandibular joint pain and dysfunction with a polymorphism in the serotonin transporter gene. Am J Orthod Dentofacial Orthop 2001 120 : 308 13.
51. Mutlu N, Erdal ME, Herken H, Oz G, Bayazit YA. T102C polymorphism of the 5-HT2A receptor gene may be associated with temporomandibular dysfunction. Oral Dis 2004 10 : 349 52.
52. Von Korff M, Le Resche L, Dworkin SF. First onset of common pain symptoms: a prospective study of depression as a risk factor. Pain 1993 55 : 251 8.
53. John MT, Miglioretti DL, Le Resche L, Von Korff M, Critchlow CW. Widespread pain as a risk factor for dysfunctional temporomandibular disorder pain. Pain 2003 102 : 257 63.
54. 2 adrenergic receptor define psychological profile, blood pressure, and the risk for development of a common musculoskeletal pain disorder. Am J Med Genet B 2006 141B : 449 62.
55. Kim H, Neubert JK, Rowan JS, Brahim JS, Iadarola MJ, Dionne RA. Comparison of experimental and acute clinical pain responses in humans as pain phenotypes. J Pain 2004 5 : 377 84.
56. Kim H, Neubert JK, San Miguel A, Xu K, Krishnaraju RK, Iadarola MJ et al. Genetic influence on variability in human acute experimental pain sensitivity associated with gender, ethnicity and psychological temperament. Pain 2004 109 : 488 96.
57. Nahmani L, Serviere F, Thomas M. Genetic etiological factors in temporomandibular joint pain dysfunction syndrome.Study of HLA-A and HLA-B antigens. Actual Odontostomatol (Paris) 1985 39 : 731 41.
58. Yu SB, Wang MQ, Zhao W, Cao HT, Liu YL. The effects of age and sex on the expression of aromatase in the rat temporomandibular joint. J Orofac Pain 2006 20 : 156 65.
59. Henry CH, Nikaein A, Wolford LM. Analysis of human leukocyte antigens in patients with internal derangement of the temporomandibular joint. J Oral Maxillofac Surg 2002 60 : 778 83.
60. Helenius LM, Hallikainen D, Helenius I, Meurman JH, Koskimies S, Tervahartiala P et al. HLA-DRB1* alleles and temporomandibular joint erosion in patients with various rheumatic diseases. Scand J Rheumatol 2004 33 : 24 9.
61. Le J, Vilcek J. Tumor necrosis factor and interleukin-1: cytokines with multiple overlapping biological activities. Lab Invest 1987 56 : 234 48.
62. Movat HZ. Tumor necrosis factor and interleukin-1: role in acute inflammation and microvascular injury. J Lab Clin Med 1987 110 : 668 81.
63. Gordon C, Wofsy D. Effects of recombinant murine tumor necrosis factor-alpha on immune function. J Immunol 1990 144 : 1753 8.
64. Sandler NA, Buckley MJ, Cillo JE, Braun TW. Correlation of inflammatory cytokines with arthroscopic findings in patients with temporomandibular joint internal derangements. J Oral Maxillofac Surg 1998 56 : 534 43.
65. Lai YC, Shaftel SS, Miller JH, Tallents RH, Chang Y, Pinkert CA et al. Intraarticular induction of interleukin-1β expression in the adult mouse, with resultant temporomandibular joint pathologic changes, dysfunction, and pain. Arthritis Rheum 2006 54 : 1184 97.
66. Ogura N, Akutsu M, Tobe M, Sakamaki H, Abiko Y, Kondoh T. Microarray analysis of IL-1β-stimulated chemokine genes in synovial fibroblasts from human TMJ. J Oral Pathol Med 2007 36 : 223 8.
67. Lark MW, Bayne EK, Flanagen J, Harper CF, Hoerrner LA, Hutchinson NI et al. Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints. J Clin Invest 1997 100 : 93 106.
68. Yoshida K, Takatsuka S, Hatada E, Nakamura H, Tanaka A, Ueki K et al. Expression of matrix metalloproteinases and aggrecanase in the synovial fluids of patients with symptomatic temporomandibular disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006 102 : 22 7.
69. Yoshida K, Takatsuka S, Tanaka A, Hatada E, Nakamura H, Nakagawa K et al. Aggrecanase analysis of synovial fluid of temporomandibular joint disorders. Oral Dis 2005 11 : 299 302.
70. Li S, Jin Y, Wang H, Li Y. Role of apoptosis and bcl-2 gene in the temporomandibular joint development. Hua Xi Kou Qiang Yi Xue Za Zhi 1999 17 : 205 7.
71. Li S, Jin Y, Wang H. The role of bcl-2 and bax genes and programmed cell death in the temporomandibular joint development. Zhonghua Kou Qiang Yi Xue Za Zhi 2000 35 : 266 8.
72. Shibukawa Y, Young B, Wu C, Yamada S, Long F, Pacifici M et al. Temporomandibular joint formation and condyle growth require Indian hedgehog signaling. Dev Dyn 2007 236 : 426 34.
73. Meng J, Ma X, Ma D, Xu C. Microarray analysis of differential gene expression in temporomandibular joint condylar cartilage after experimentally induced osteoarthritis. Osteoarthritis Cartilage 2005 13 : 1115 25.
74. Zucchero T, Cooper ME, Maher BS, Daack-Hirsch S, Nepomuceno B, Ribeiro L et al. Interferon regulatory factor (IRF6) is a modifier for isolated cleft lip and palate. New Engl J Med 2004 351 : 769 80.
75. Vieira AR, Modesto A, Meira R, Barbosa ARS, Lidral AC, Murray JC. Interferon regulatory factor 6 (IRF6) and fibroblast growth factor receptor 1 (FGFR1) contribute to human tooth agenesis. Am J Med Genet A 2007 143A : 538 45.
76. Harinstein D, Buckingham RB, Braun T, Oral K, Bauman DH, Killian PJ et al. Systemic joint laxity (the hypermobile joint syndrome) is associated with temporomandibular joint dysfunction. Arthritis Rheum 1988 31 : 1259 64.
77. Beighton P, Grahame R, Bird H. Hypermobility of Joints. Berlin : Springer Verlag 1989.
78. Russek LN. Hypermobility syndrome. Phys Ther 1999 79 : 591 9.
79. Murray KJ. Hypermobility disorders in children and adolescents. Best Pract Res Clin Rheumatol 2006 20 : 329 51.
80. Ivasenko PI, Iakovlev VM, Ignat'ev IT, Savchenko RK, Kozhikhova NP. Dysplasia-dependent abnormalities of the temporomandibular joint. Stomatologiia (Mosk) 2001 80 : 43 6.
81. De Coster PJ, Martens LC, De Paepe A. Oral health in prevalent types of Ehlers-Danlos syndromes. J Oral Pathol Med 2005 34 : 298 307.
82. Simonenko VB, Dulin PA, Panfilov DN, Beliaev LB, Makanin MA, Denishchuk IS et al. Connective tissue dysplasias (hereditary collagenopathies). Klin Med (Mosk) 2006 84 : 62 8.
83. Ahmed N, Bloch-Zupan A, Murray KJ, Calvert M, Roberts GJ, Lucas VS. Oral health of children with juvenile idiopathic arthritis. J Rheumatol 2004 31 : 1639 43.
84. Savioli C, Silva CA, Lin HC, Campos LM, Prado EF, Siqueira T. Dental and facial characteristics of patients with juvenile idiopathic arthritis. Rev Hosp Clin Fac Med São Paulo 2004 59 : 93 8.
85. Van Sickels JE, Gruber AB, Kagan-Hallet KS, Dowd DC. Mitochondrial myopathy presenting as temporomandibular dysfunction. J Oral Maxillofac Surg 1987 63 : 168 72.
86. Cousley R, Naora H, Yokoyama M, Kimura M, Otani H. Validity of the Hfm transgenic mouse as a model for hemifacial microsomia. Cleft Palate Craniofac J 2002 39 : 81 92.